Harmony Biosciences (HRMY) Earnings Date, Estimates & Call Transcripts

$35.59

+0.03 (+0.08%)

(As of 09/6/2024 ET)

Upcoming Earnings Date: Oct. 29Estimated
Actual EPS (Aug. 6): $0.20 Beat By $0.24
Consensus EPS (Aug. 6): -$0.04

HRMY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HRMY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Deal Maker

The solution to fast food’s wage hike crisis

Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.

Learn more about this much-needed advancement and investment opportunity here.

Harmony Biosciences Analyst EPS Estimates

Current Year EPS Consensus Estimate:$2.19 EPS
Next Year EPS Consensus Estimate: $3.49 EPS

HRMY Earnings Date and Information

Harmony Biosciences last released its quarterly earnings results on August 6th, 2024. The reported $0.20 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.24. The business had revenue of $172.80 million for the quarter, compared to analysts' expectations of $172.53 million. Its revenue was up 28.8% compared to the same quarter last year. Harmony Biosciences has generated $2.31 earnings per share over the last year ($2.31 diluted earnings per share) and currently has a price-to-earnings ratio of 15.4. Earnings for Harmony Biosciences are expected to grow by 59.36% in the coming year, from $2.19 to $3.49 per share. Harmony Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 29th, 2024 based off prior year's report dates.

Harmony Biosciences Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
10/29/2024 (Estimated)	-	-	-	-	-	-	-
8/6/2024	Q2 2024	($0.04)	$0.20	+$0.24	$0.20	$172.53 million	$172.80 million
4/30/2024	Q1 2024	$0.60	$0.67	+$0.07	$0.67	$154.10 million	$154.62 million
2/22/2024	Q4 2023	$0.74	$0.45	($0.29)	$0.45	$168.90 million	$168.40 million
10/31/2023	Q3 2023	$0.67	$0.63	($0.04)	$0.63	$147.83 million	$160.30 million
8/1/2023	Q2 2023	$0.62	$0.56	($0.06)	$0.56	$139.79 million	$134.22 million
5/2/2023	Q1 2023	$0.44	$0.48	+$0.04	$0.48	$118.21 million	$119.13 million
Get the Latest News and Ratings for HRMY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Harmony Biosciences and its competitors with MarketBeat's FREE daily newsletter.
2/21/2023	Q4 2022	$0.54	$1.01	+$0.47	$1.23	$127.73 million	$128.31 million
11/1/2022	Q3 2022	$0.10	$0.95	+$0.85	$0.46	$113.11 million	$117.21 million
8/2/2022	Q2 2022	$0.40	$0.57	+$0.17	$0.75	$99.35 million	$107.03 million
5/3/2022	Q1 2022	$0.25	$0.51	+$0.26	$0.67	$87.77 million	$85.31 million
2/28/2022	Q4 2021	$0.32	$0.63	+$0.31	$0.88	$88.43 million	$91.21 million
11/8/2021	Q3 2021	$0.29	($0.17)	($0.46)	$1.03	$79.30 million	$80.73 million
8/9/2021	Q2 2021	$0.18	$0.24	+$0.06	$0.84	$70.85 million	$73.82 million
5/10/2021	Q1 2021	($0.03)	$0.38	+$0.41	$0.63	$59.60 million	$59.67 million
3/24/2021	Q4 2020	$0.09	$0.25	+$0.16	$0.50	$51.50 million	$56.29 million
11/17/2020	Q3 2020	($0.05)	($0.14)	($0.09)	($0.14)	$40.10 million	$45.61 million

Harmony Biosciences Earnings - Frequently Asked Questions

When is Harmony Biosciences's earnings date?: Harmony Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 29th, 2024 based off last year's report dates. Learn more on HRMY's earnings history.
What guidance has Harmony Biosciences issued on next quarter's earnings?: Harmony Biosciences issued an update on its FY 2024 earnings guidance on Tuesday, August, 6th. The company issued revenue guidance of $700.0 million-$720.0 million, compared to the consensus revenue estimate of $709.4 million.
Did Harmony Biosciences beat their earnings estimates last quarter?: In the previous quarter, Harmony Biosciences (NASDAQ:HRMY) reported $0.20 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.04) by $0.24. Learn more on analysts' earnings estimate vs. HRMY's actual earnings.
How can I listen to Harmony Biosciences's earnings conference call?: The conference call for Harmony Biosciences's latest earnings report can be listened to online. Listen to Conference Call
How can I read Harmony Biosciences's conference call transcript?: The conference call transcript for Harmony Biosciences's latest earnings report can be read online. Read Transcript
How much revenue does Harmony Biosciences generate each year?: Harmony Biosciences (NASDAQ:HRMY) has a recorded annual revenue of $656.11 million.
How much profit does Harmony Biosciences generate each year?: Harmony Biosciences (NASDAQ:HRMY) has a recorded net income of $128.85 million. HRMY has generated $2.31 earnings per share over the last four quarters.
What is Harmony Biosciences's price-to-earnings ratio?: Harmony Biosciences (NASDAQ:HRMY) has a trailing price-to-earnings ratio of 15.41 and a forward price-to-earnings ratio of 16.25. The price/earnings-to-growth ratio is 0.72.
What is Harmony Biosciences's EPS forecast for next year?: Harmony Biosciences's earnings are expected to grow from $2.19 per share to $3.49 per share in the next year, which is a 59.36% increase.